Literature DB >> 18535031

Seroprotection against serogroup C meningococcal disease.

Lucieni O Conterno, Paul T Heath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18535031      PMCID： PMC2440850          DOI： 10.1136/bmj.39577.487558.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

Authors:  Martin C J Maiden; James M Stuart
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

2.  Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis.

Authors:  Mary E Ramsay; Nick J Andrews; Caroline L Trotter; Edward B Kaczmarski; Elizabeth Miller
Journal:  BMJ       Date:  2003-02-15

3.  Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom.

Authors:  Cressida Auckland; Stephen Gray; Ray Borrow; Nick Andrews; David Goldblatt; Mary Ramsay; Elizabeth Miller
Journal:  J Infect Dis       Date:  2006-11-08       Impact factor: 5.226

4.  Epidemiology of invasive meningococcal disease in France in 2003.

Authors:  A Perrocheau; M K Taha; D Levy-Bruhl
Journal:  Euro Surveill       Date:  2005-12

5.  Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.

Authors:  Philippe De Wals; Geneviève Deceuninck; Nicole Boulianne; Gaston De Serres
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

6.  Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

Authors:  E Miller; D Salisbury; M Ramsay
Journal:  Vaccine       Date:  2001-10-15       Impact factor: 3.641

7.  Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

Authors:  R Borrow; N Andrews; D Goldblatt; E Miller
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.

Authors:  Nick Andrews; Ray Borrow; Elizabeth Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

9.  Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.

Authors:  M D Snape; D F Kelly; S Lewis; C Banner; L Kibwana; C E Moore; L Diggle; T John; L M Yu; R Borrow; A Borkowski; C Nau; A J Pollard
Journal:  BMJ       Date:  2008-06-05

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
View more
  1 in total

1.  Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Authors:  Andrew J Pollard; Kirsten P Perrett; Peter C Beverley
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.